Providers

Litholink, a LabCorp subsidiary, has developed a programmatic approach to comprehensively treat kidney stone disease. Using this approach, we are able to reduce the rate of kidney stone recurrence up to 80%.

Our Kidney Stone Patient Results Report

Litholink’s report provides time sequential data and analysis of stone risk factors with therapeutic suggestions.

LEARN MORE


Enroll Online

Click below to sign up for the Litholink Kidney Stone Prevention program!

ENROLL NOW


Our Kidney Stone Prevention Program

Dr. Fredric Coe, a leading expert in kidney stone disease, founded Litholink to bring state-of-the-art kidney stone treatment techniques to physicians nationwide.

LEARN MORE